Learn more

AVARIS AB

Overview
  • Total Patents
    41
About

AVARIS AB has a total of 41 patent applications. Its first patent ever was published in 1998. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are AMVAC AG, ANTISENSE THERAPEUTICS LTD and INT STEM CELL CORPORATION.

Patent filings per year

Chart showing AVARIS ABs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Smith Edvard 18
#2 Branden Lars 13
#3 Dilber Sirac 9
#4 Aints Alar 8
#5 Johansson Ulrika 6
#6 Walther-Jallow Lilian 6
#7 Spetz-Holmgren Anna-Lena 6
#8 Svahn Mathias 5
#9 Andersson Jan 5
#10 Treschow Alexandra 5

Latest patents

Publication Filing date Title
WO2010110734A1 Expansion of nk cells
EP2376518A1 A complex and method for enhancing nuclear delivery
US2009123442A1 Expanded nk cells
GB0622399D0 Novel compositions and uses thereof
GB0622400D0 Novel compositions and uses thereof
US2010041738A1 Hybridization-stabilizing construct
EP1896570A2 Cellular vaccine and use thereof
WO2006078217A1 COMPLEX CONTAINING SiRNA, ShRNA OR ANTISENSE MOLECULE AND FUNCTIONAL ENTITY, FOR IMPROVED SPECIFICITY AND DELIVERY
EP1781777A1 Method for the genetic activation of cells and uses of said cells
EP1597362A1 Cardiac glycoside resistant non-immunogenic selection marker
US2006228343A1 Cells having cardiac glycoside resistance
WO03091443A1 Synthetic transfer complex and method for transferring nucleic acids
US7824853B2 Complex comprising at least two biospecific elements separated by a nucleic acid linker e.g. for identification of drug delivery candidates combinatorial library of such complexes
US6869796B2 Method of introducing organic molecules into target cells
US6720310B1 Transfer method for specific cellular localization of nucleic acids